Riskpilot← Back to searchSign inGet full accessApS NORA BIO
APSActiveCVR 15206381Hambros Alle 1Rental and operating of own or leased real estate · NACE 6820Est. 1991— employees
Revenue 2024
DKK 2,6M
-13% vs 2023
EBITDA margin
119.5%
+9% vs 2023
Equity ratio
58.9%
Financial strength
Net profit 2024
DKK 2,6M
+12% vs 2023
| Revenue | DKK 2,6M | -13% |
| EBITDA | DKK 3,2M | +9% |
| Net profit | DKK 2,6M | +12% |
| Total assets | DKK 51,6M | +4% |
| Equity | DKK 30,4M | +9% |
| Employees | — | — |
Legal name
ApS NORA BIO
CVR number
15206381
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
1. juni 1991
Share capital
DKK 200.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at drive investering, finansiering og handel samt anden dermed efter ledelsens skøn beslægtet virksomhed
Address
Hambros Alle 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.248 | 3.286 | 2.592 | 2.419 | 2.494 | 2.605 | 2.548 | 2.514 | 3.354 | 2.658 | 2.819 | 3.032 | 2.638 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 4.176 | 1.032 | 2.742 | 2.569 | 5.794 | 3.405 | 2.598 | 2.539 | 2.799 | 2.933 | 14.919 | 2.882 | 3.153 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 4.176 | 1.032 | 2.742 | 2.569 | 5.794 | 3.405 | 2.598 | 2.539 | 2.799 | 2.933 | 14.919 | 2.882 | 3.153 |
| Net financials | -1.571 | 12.409 | 5.456 | 298 | -443 | -178 | -118 | -311 | 145 | 4 | -44 | 51 | 141 |
| Profit before tax | 2.606 | 13.441 | 8.198 | 2.867 | 5.352 | 3.227 | 2.480 | 2.228 | 2.944 | 2.937 | 14.875 | 2.933 | 3.294 |
| Tax | 797 | 51 | 30 | 664 | 1.177 | 710 | 546 | 490 | 648 | 646 | 3.273 | 645 | 725 |
| Net profit | 1.809 | 13.390 | 8.168 | 2.202 | 4.174 | 2.517 | 1.935 | 1.738 | 2.296 | 2.291 | 11.603 | 2.288 | 2.569 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 56.694 | 69.852 | 65.248 | 29.900 | 34.816 | 36.999 | 38.365 | 39.925 | 42.445 | 33.824 | 47.660 | 49.682 | 51.597 |
| Equity | 22.241 | 35.629 | 43.797 | 9.000 | 13.174 | 15.691 | 17.626 | 19.364 | 21.660 | 13.951 | 25.554 | 27.841 | 30.410 |
| Long-term debt | 17.004 | 16.459 | 15.939 | 15.166 | 14.704 | 14.036 | 13.427 | 13.293 | 12.721 | 12.129 | 11.580 | 11.051 | 10.446 |
| Short-term debt | 12.522 | 12.783 | 951 | 1.036 | 1.459 | 1.548 | 1.508 | 1.390 | 2.084 | 1.633 | 1.685 | 1.912 | 1.732 |
| Total debt | 29.526 | 29.242 | 16.890 | 16.201 | 16.163 | 15.583 | 14.936 | 14.683 | 14.804 | 13.763 | 13.264 | 12.963 | 12.178 |
EBITDA margin
119.5%
This company
15.8%
Market median
+656% vs market
20122024
Equity ratio
58.9%
This company
38.2%
Market median
+54% vs market
20122024
Return on equity
8.4%
This company
18.4%
Market median
-54% vs market
20122024
Net profit margin
97.4%
This company
8.1%
Market median
+1102% vs market
20122024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20122024
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ET | Audit | 1991 | — | — |
DC Management | Management | 2021 | — | — |
SS Management | Management | 1991 | — | — |
MC Management | Management | 1991 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1991 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Adyn Ejendomme ApS | Company | 100.0% | 100.0% | 2020 |
ADYN ApS | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nicolai C Holding ApS
ApS NORA BIO Board members of ApS NORA BIO also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Tronborg Andersen | Audit | 0 companies |
| David Choleva | Management | 0 companies |
| Susanne Saul Stakemann | Management | 0 companies |
| Marcus Choleva | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |